Tag: Dr Reddy’s
Growing significance of packaging at CPHI & PMEC India 2024
The 17 edition of CPHI & PMEC India, organized by Informa Markets, was held at the India Expo Mart and Centre, Greater Noida, Delhi-NCR....
US FDA resumes inspections in India
In February 2022, FDA officials stated that the agency is eager to resume inspections, including surprise inspections in India. On Thursday, 10 March 2022,...
Cipla, Dr. Reddy’s, Emcure, Sun Pharma & Torrent to collaborate for...
On 29 June 2021, five Indian Indian pharma companies announced their collaboration for a clinical trial of the anti-viral drug Molnupiravir. Cipla, Dr Reddy’s...
Glenmark to divest select anti-allergy brands to Dr Reddy’s in Russia,...
Glenmark Pharmaceuticals announced that it has entered into a definitive agreement with Dr Reddy's Laboratories to divest - subject to completion of specific precedent...
Dr Reddy’s launches Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection
Dr Reddy's announced the launch of Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, a therapeutic equivalent generic version of Precedex (dexmedetomidine hydrochloride) in 0.9%...
Dr Reddy’s Laboratories launches Avigan (Favipiravir) in India
Dr Reddy's Laboratories announced the launch of Avigan (Favipiravir) 200 mg tablets in India. The launch is part of the global licensing agreement with...